URB754 Has No Effect on the Hydrolysis or Signaling Capacity of 2-AG in the Rat Brain  by Saario, Susanna M. et al.
Chemistry & Biology 13, 811–814, August 2006 ª2006 Elsevier Ltd All rights reserved DOI 10.1016/j.chembiol.2006.07.008Brief CommunicationURB754 Has No Effect
on the Hydrolysis or Signaling
Capacity of 2-AG in the Rat BrainSusanna M. Saario,1,* Ville Paloma¨ki,2
Marko Lehtonen,1 Tapio Nevalainen,1
Tomi Ja¨rvinen,1 and Jarmo T. Laitinen2
1Department of Pharmaceutical Chemistry
2 Institute of Biomedicine
Department of Physiology
University of Kuopio
P.O. Box 1627
FIN-70211 Kuopio
Finland
Summary
Previous studies indicate that in brain tissue the endo-
cannabinoid 2-AG is inactivated by monoglyceride li-
pase (MGL)-catalyzed hydrolysis, and a recent report
has indicated that MGL activity could be specifically in-
hibited by URB754 [1]. In the present study, URB754
failed to inhibit 2-AG hydrolysis in rat brain prepara-
tions. In addition, brain cryosections were employed
to assess whether URB754 could facilitate the detec-
tion of 2-AG-stimulated G protein activity. Neverthe-
less, whereas pretreatment with PMSF readily allowed
detection of 2-AG-stimulated G protein activity, URB754
was ineffective. In contrast to previous claims, brain
FAAH activity was also resistant to URB754. Thus, in
our hands URB754 was not able to block the endocan-
nabinoid-hydrolyzing enzymes and cannot serve as a
lead structure for future development of MGL-specific
inhibitors.
Introduction
2-Arachidonoyl-glycerol (2-AG), a monoglyceride of
arachidonic acid esterified at the sn-2 position, is cur-
rently recognized as the most abundant and potent en-
docannabinoid. The synthesis, release, and degradation
of neuromodulatory 2-AG is thought to occur in close
proximity to the cannabinoid CB1 receptor-enriched
neuronal structures. This guarantees a restricted spatial
coordination for the action of this unique lipid messen-
ger. In vivo, the effects of 2-AG are transient, partly
due to its rapid and efficient enzymatic hydrolysis. The
main enzyme responsible for 2-AG hydrolysis in brain
tissue is thought to be monoglyceride lipase (MGL) [2,
3]. Since the role of MGL as a 2-AG hydrolyzing enzyme
in the cannabinoid system has only recently been eluci-
dated, few MGL inhibitors have been developed. How-
ever, it is known that purified MGL, as well as 2-AG-de-
grading enzymatic activity in rat cerebellar membranes,
can be inhibited by various nonspecific serine hydrolase
inhibitors, most notably MAFP, HDSF, and PMSF [2, 4].
Additionally, sulfhydryl-specific compounds, including
pCMB, mercury chloride, and NEM have previously
been shown to inhibit MGL [5, 6]. We have also reported
that 2-AG hydrolysis in rat cerebellar membranes was
*Correspondence: susanna.saario@uku.firelatively potently (IC50 140 nM) inhibited by a maleimide
analog of 2-AG,N-arachidonylmaleimide (NAM) [7]. A re-
cent report claimed that MGL activity can be specifically
and noncompetitively inhibited by two compounds,
URB754 and URB602 (IC50 values 200 nM and 75 mM,
respectively) [1]. In the present study, URB754 and
URB602 were tested for their potential to inhibit 2-AG
hydrolysis in rat brain homogenates and membrane
preparations. In addition, brain sections were employed
to assess whether URB754 could promote endogenous
2-AG accumulation or whether treatment with this com-
pound could facilitate the detection of 2-AG-stimulated
G protein activity in brain regions enriched with the CB1
receptor and MGL. Our results provide no evidence to
support the claim that URB754 and URB602 are inhibi-
tors of 2-AG hydrolysis in the rat brain.
Results and Discussion
Makara et al. [1] reported that URB754 and URB602
could inhibit recombinant rat brain MGL in HeLa cells
with IC50 values of 200 nM and 75 mM, respectively. Ad-
ditionally, that report claimed that URB754 was able to
elevate 2-AG levels in rat forebrain slice cultures and
to prolong depolarization-induced suppression of inhi-
bition (DSI) in hippocampal slices in a CB1 receptor-
dependent manner. We tested these two compounds
in various experimental settings assessing enzymatic
degradation and signaling capacity of 2-AG in brain
preparations. As is evident from Figure 1, the hydrolysis
of exogenously added 2-AG (5 3 1025 M) in rat cerebel-
lar membranes (CbM) was not inhibited by URB754
(100 mM). The outcome was essentially the same regard-
less of whether BSA (0.5% w/v) was included (as in Fig-
ure 1) or not (data not shown). Moreover, less than 10%
of 2-AG hydrolyzing activity in homogenates of rat fore-
brain (BrH) and cerebellum (CbH), two brain regions with
prominent expression of mRNA encoding MGL [2], was
sensitive to URB754 (100 mM) (Figure 1). The structure
of URB754 used in the present study was confirmed by
1H NMR spectroscopy to be identical to that reported
by Garin et al. [8] and by Makara et al. [1] (data not shown).
Similarly, URB602 (1 mM) did not inhibit 2-AG hydrolysis in
rat cerebellar membranes, and only w12% inhibition
was evident in brain homogenates. Consistent with our
previous findings [7], NAM (1 mM) inhibitedw90% of 2-
AG hydrolyzing activity in cerebellar membranes, and
this was also the case with brain homogenates (Figure 1).
The negative outcome with these novel putative inhibi-
tors was rather surprising, especially in the light of the
previous reports that the brain 2-AG hydrolyzing activity
(assumed to be MGL) [9] as well as that of recombinant
MGL [2] is found in both cytosolic and particulate frac-
tions. Further, immunodepletion experiments have indi-
cated that MGL accounts for at least 50% of the 2-AG-
hydrolyzing activity in rat brain soluble fractions [3].
One explaining factor could be that MGL, which in the
hippocampus and the cerebellum is localized to the pre-
synaptic terminals in close proximity with the CB1 recep-
tors [10], might only represent a minor fraction of the total
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812Figure 1. Hydrolysis of 2-AG in NAM,
URB754, and URB602 Pretreated Rat Cere-
bellar Membranes, Brain Homogenate, and
Cerebellar Homogenate
The enzyme activity of control samples was
expressed as 100%. The data represent the
mean 6 SD from three independent experi-
ments performed in duplicate. An asterisk
denotes a statistically significant (*p < 0.05)
difference from the respective control.
CbM, pretreated rat cerebellar membranes;
BrH, brain homogenate; CbH, cerebellar
homogenate.2-AG-hydrolyzing enzymatic capacity in the presently
used brain preparations. To test this hypothesis, the ef-
fectiveness of URB754 in potentiating 2-AG-stimulated
and CB1 receptor-dependent G protein activity was as-
sessed using the functional approach of [35S]GTPgS
autoradiography with rat brain cryostat sections. Our
previous studies have indicated that brain sections ef-
fectively degrade 2-AG. In fact, this phenomenon has
complicated attempts to visualize 2-AG-stimulated re-
sponses, in contrast to the robust responses evoked
by the synthetic agonist CP55,940 [11]. As shown in Fig-
ure 2, pretreatment with PMSF (1 mM, at concentrations
that almost totally eliminated 2-AG hydrolyzing activity in
the cerebellar membranes) [4] allowed clear visualization
of 2-AG-stimulated G protein activity throughout the
CB1-responsive brain regions, whereas a similar treat-
ment with URB754 (10 mM) was ineffective. Additional
studies revealed that incubation of brain sections in
Tris-HCl-based buffer with submicromolar concentra-
tions of MAFP approximately quadrupled the tissue 2-
AG content, as determined by GC-MS analysis of chloro-
form-methanol-extracted brain sections, but 2-AG levels
were not elevated following treatment with URB754
(10 mM) (V.P. et al., unpublished data).
Makara et al. [1] reported that URB754 could also
inhibit native rat brain FAAH with an IC50 value of
31.8 mM. However, in our test system, URB754 did not
inhibit rat brain FAAH by more than 10% at the highest
concentration (100 mM) tested (n = 2, data not shown).
Nevertheless, the previously reported potent FAAH in-
hibitor URB597 [12] was found to inhibit FAAH with an
IC50 value of 3.8 nM [13], which is comparable to the pre-
viously reported IC50 value of 4.6 nM [12].
There are two possibilities to explain the discrepant
findings between our study and that of Makara et al.
[1]. The first explanation is that the previously character-
ized 2-AG hydrolyzing activity in rat brain must be differ-
ent from the URB754-sensitive MGL activity described
by Makara et al. [1]. However, this line of argument is
not supported by several pieces of evidence. Previous
immunodepletion experiments indicate that MGL ac-
counts for at least 50% of the 2-AG-hydrolyzing activity
in rat brain soluble fractions [3], and this activity is ex-
pected to be fully preserved in the brain homogenates
and tissue sections used in this study. As clearly shown
here, URB754 only marginally affected 2-AG hydrolysis
in brain homogenates and was devoid of activity in brain
sections assessing the CB1 receptor-dependent signal-
ing capacity of 2-AG. This means that it is unlikely that
the majority of 2-AG hydrolase activity in rat brain would
correspond to some MGL-like activity mediated by apharmacologically similar but nonetheless different
enzyme from the purified MGL [2, 14], with the only dif-
ference being sensitivity of MGL to URB754. The sec-
ond, and to our opinion more likely, explanation is that
for some unknown reason, the effects attributed to
URB754 [1] in fact represent activity related to another
chemical entity. This is supported by the fact that the
human recombinant MGL, which at the amino acid level
is highly homologous to the rat and mouse MGL, does
not appear to be sensitive to URB754 [15].
Figure 2. Treatment of Rat Brain Sections with PMSF Allows De-
tection of 2-AG-Stimulated G Protein Activity throughout the CB1
Receptor-Enriched Brain Regions, Whereas Similar Treatment
with URB754 Is Ineffective
Horizontal brain sections were processed for [35S]GTPgS autoradi-
ography using a three-step assay protocol as detailed in the Exper-
imental Procedures. PMSF (1 mM) was present in step 2, and
URB754 (10 mM) throughout steps 2 and 3. [35S]GTPgS labeling
was conducted for 90 min under basal conditions or in the pres-
ence of the cannabinoid agonists. Note that in PMSF-treated sec-
tions, 2-AG and the synthetic cannabinoid agonist CP55,940 stim-
ulate [35S]GTPgS binding to the same CB1 receptor-enriched brain
regions, most notably in the caudate putamen (CPu), the globus
pallidus (GP), the hippocampus (hip), and the cerebral cortex
(Ctx). Note also that URB754 totally lacks such a 2-AG signal-
enhancing effect.
URB754 Does Not Inhibit 2-AG Hydrolysis in Rat Brain
813Significance
In this present study, the newly introduced MGL inhib-
itors URB754 and URB602 showed no significant in-
hibitory effect on the hydrolysis of 2-AG in rat brain
preparations. In addition, URB754 failed to potentiate
2-AG signaling in rat brain sections. In the light of
the present findings, we do not believe that URB754
will serve as a lead structure for further development
of MGL-specific inhibitors. The development of spe-
cific inhibitors for the enzyme responsible for 2-AG hy-
drolysis may provide valuable molecular tools to clar-
ify the physiological role of 2-AG. Furthermore, such
inhibitors could offer a rational approach for the treat-
ment of certain pathological states, such as pain and
anxiety.
Experimental Procedures
Materials
2-AG, URB754, and URB602 were purchased from Cayman Chemi-
cal (Ann Arbor, MI). BSA (essentially fatty acid free) was purchased
from Sigma (St. Louis, MO).
Animals and Preparation of Membranes and Homogenates
The animals and membrane preparations have been described pre-
viously [7]. Briefly, rat brain cerebella from 4-week-old male Wistar
rats were homogenized and centrifuged first at 1,000 3 g for 10
min and subsequently at 100,0003g for 10 min (at 4C). The resulting
pellet was referred to as the rat cerebellar membranes (CbM). Ho-
mogenates from forebrains and cerebella from 8-week-old male
Wistar rats were centrifuged at 10,000 3 g for 20 min (at 4C), and
the resulting supernatants were referred to as the rat brain homoge-
nate (BrH)and the rat cerebellumhomogenate (CbH), respectively [13].
Enzyme Assay for MGL Activity
The assay for MGL has been described previously [7]. Briefly, CbM
(10 mg protein), BrH (35 mg protein), and CbH (35 mg protein) were in-
cubated with the test compounds at 25C (pH 7.4) for 30 min. After
the preincubations, the substrate 2-AG was added, and incubations
were continued for 90 min prior to addition of acetonitrile (the pH of
the samples was simultaneously decreased to 3.0 with phosphoric
acid) and HPLC analysis (described previously [4]). The final incuba-
tion volume contained 5 mg CbM, 17.5 mg of BrH or CbH protein,
0.5% (w/v) BSA (fatty acid free), and 50 mM of 2-AG.
Enzyme Assay for FAAH Activity
The assay for FAAH has been described by Saario et al. (2006) [13].
Briefly, BrH (18 mg protein) was incubated with test compound for
10 min at 37C (pH 7.4). At the 10 min time point, the substrate,
AEA, was added so that its final concentration was 2 mM (containing
50 3 1023 mCi of 60 Ci/mmol [3H]AEA). The incubations were per-
formed in the presence of 0.5% (w/v) BSA (essentially fatty acid
free). Ethyl acetate was added at the 20 min time point to stop
the enzymatic reaction. Additionally, unlabeled ethanolamine was
added as a ‘‘carrier’’ for radioactive ethanolamine, which was mea-
sured by liquid scintillation counting.
[35S]GTPgS Autoradiography
20 mm thick horizontal cryosections from 4-week-old male Wistar
rats were incubated in three sequential steps (20, 60, and 90 min)
in Tris-HCl buffer (50 mM Tris-HCl [pH 7.4], 1 mM EDTA, 100 mM
NaCl, 5 mM MgCl2) at 20
C, essentially as previously described
[16, 17]. Throughout steps 2 and 3, the buffer was supplemented
with GDP (2 mM), BSA (0.5%), 8-cyclopentyl-1,3-dipropylxanthine
(1 mM) along with the vehicle (DMSO), URB754 (10 mM), or PMSF
(1 mM, only step 2). [35S]GTPgS binding was conducted for 90 min
in the presence of DTT (1 mM) and either vehicle (ethanol), 2-AG
(50 mM), or CP55,940 (5 mM). Sections were washed twice (5 min
each time) in buffer (50 mM Tris-HCl [pH 7.4], 5 mM MgCl2, 0
C)
and briefly dipped in Millipore water (0C, 30 s). The sections wereexposed on BioMax MR, Kodak Scientific Imagin Film for 4 days,
and film was developed using Kodak D-19 developer and scanned
with HP digitalized 7400c.
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